ARCHIVES

NCI Largely Unaffected By NIH Translational Research Center

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

NCI-Approved Clinical Trials

December 30, 2005

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011